BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 22386940)

  • 21. Molecular genetic study of congenital nephrogenic diabetes insipidus and rescue of mutant vasopressin V2 receptor by chemical chaperones.
    Cheong HI; Cho HY; Park HW; Ha IS; Choi Y
    Nephrology (Carlton); 2007 Apr; 12(2):113-7. PubMed ID: 17371330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional characterization of the molecular defects causing nephrogenic diabetes insipidus in eight families.
    Pasel K; Schulz A; Timmermann K; Linnemann K; Hoeltzenbein M; Jääskeläinen J; Grüters A; Filler G; Schöneberg T
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1703-10. PubMed ID: 10770218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diverse vasopressin V2 receptor functionality underlying partial congenital nephrogenic diabetes insipidus.
    Faerch M; Christensen JH; Rittig S; Johansson JO; Gregersen N; de Zegher F; Corydon TJ
    Am J Physiol Renal Physiol; 2009 Dec; 297(6):F1518-25. PubMed ID: 19812297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A large deletion of the AVPR2 gene causing severe nephrogenic diabetes insipidus in a Turkish family.
    Saglar E; Deniz F; Erdem B; Karaduman T; Yönem A; Cagiltay E; Mergen H
    Endocrine; 2014 May; 46(1):148-53. PubMed ID: 24026507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A female with X-linked Nephrogenic diabetes insipidus in a family with inherited central diabetes Insipidus: Case report and review of the literature.
    Ding C; Beetz R; Rittner G; Bartsch O
    Am J Med Genet A; 2020 May; 182(5):1032-1040. PubMed ID: 32073219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel AVPR2 missense mutation in an Asian family with inherited nephrogenic diabetes insipidus: A case report.
    Zhang M; Yu Q; Chen C; Han J; Cheng B; Tian D
    Medicine (Baltimore); 2019 Apr; 98(17):e15348. PubMed ID: 31027113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nephrogenic diabetes insipidus caused by mutation of Tyr205: a key residue of V2 vasopressin receptor function.
    Sangkuhl K; Römpler H; Busch W; Karges B; Schöneberg T
    Hum Mutat; 2005 May; 25(5):505. PubMed ID: 15841479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus.
    Robben JH; Knoers NV; Deen PM
    Am J Physiol Renal Physiol; 2006 Aug; 291(2):F257-70. PubMed ID: 16825342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel AVPR2 gene mutation of X-linked congenital nephrogenic diabetes insipidus in an Asian pedigree.
    Guo WH; Li Q; Wei HY; Lu HY; Qu HQ; Zhu M
    J Int Med Res; 2016 Oct; 44(5):1131-1137. PubMed ID: 27565746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. V2 vasopressin receptor dysfunction in nephrogenic diabetes insipidus caused by different molecular mechanisms.
    Schöneberg T; Schulz A; Biebermann H; Grüters A; Grimm T; Hübschmann K; Filler G; Gudermann T; Schultz G
    Hum Mutat; 1998; 12(3):196-205. PubMed ID: 9711877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Six novel mutations in the vasopressin V2 receptor gene causing nephrogenic diabetes insipidus.
    Cheong HI; Park HW; Ha IS; Moon HN; Choi Y; Ko KW; Jun JK
    Nephron; 1997; 75(4):431-7. PubMed ID: 9127330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations in the vasopressin V2 receptor gene in families with nephrogenic diabetes insipidus and functional expression of the Q-2 mutant.
    Rosenthal W; Seibold A; Antaramian A; Gilbert S; Birnbaumer M; Bichet DG; Arthus MF; Lonergan M
    Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):429-36. PubMed ID: 7920187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case of a novel mutant vasopressin receptor-dependent nephrogenic diabetes insipidus with bilateral non-obstructive hydronephrosis in a middle aged man: differentiation from aquaporin-dependent nephrogenic diabetes insipidus by response of factor VII and von Willebrand factor to 1-diamino-8-arginine vasopressin administration.
    Miyakoshi M; Kamoi K; Uchida S; Sasaki S
    Endocr J; 2003 Dec; 50(6):809-14. PubMed ID: 14709855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical phenotype of nephrogenic diabetes insipidus in females heterozygous for a vasopressin type 2 receptor mutation.
    van Lieburg AF; Verdijk MA; Schoute F; Ligtenberg MJ; van Oost BA; Waldhauser F; Dobner M; Monnens LA; Knoers NV
    Hum Genet; 1995 Jul; 96(1):70-8. PubMed ID: 7607658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physiopathology and diagnosis of nephrogenic diabetes insipidus.
    Devuyst O
    Ann Endocrinol (Paris); 2012 Apr; 73(2):128-9. PubMed ID: 22503803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular analyses of the vasopressin type 2 receptor and aquaporin-2 genes in Brazilian kindreds with nephrogenic diabetes insipidus.
    Rocha JL; Friedman E; Boson W; Moreira A; Figueiredo B; Liberman B; de Lacerda L; Sandrini R; Graf H; Martins S; Puñales MK; De Marco L
    Hum Mutat; 1999; 14(3):233-9. PubMed ID: 10477431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Molecular biological studies on patients with nephrogenic diabetes insipidus].
    Szalai C; Molnár E; Sallay P; Czinner A
    Orv Hetil; 1998 Apr; 139(15):883-7. PubMed ID: 9579101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of responsiveness to 1-desamino-D arginin vasopressin (desmopressin) in male patients with nephrogenic syndrome of inappropriate antidiuresis: from bench to bedside.
    Vandergheynst F; Pradier O; Beukinga I; Kornreich A; Vassart G; Decaux G
    Eur J Clin Invest; 2012 Mar; 42(3):254-9. PubMed ID: 21834801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hereditary Nephrogenic Diabetes Insipidus: Pathophysiology and Possible Treatment. An Update.
    Milano S; Carmosino M; Gerbino A; Svelto M; Procino G
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29125546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding-, intracellular transport-, and biosynthesis-defective mutants of vasopressin type 2 receptor in patients with X-linked nephrogenic diabetes insipidus.
    Tsukaguchi H; Matsubara H; Taketani S; Mori Y; Seido T; Inada M
    J Clin Invest; 1995 Oct; 96(4):2043-50. PubMed ID: 7560098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.